Published in J Neurol Neurosurg Psychiatry on November 01, 2005
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial. Stroke (2007) 1.44
Associations of clinical stroke misclassification ('clinical-imaging dissociation') in acute ischemic stroke. Cerebrovasc Dis (2010) 0.99
Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial. Stroke (2014) 0.81
Multiple subcortical acute ischemic lesions reflect small vessel disease rather than cardiogenic embolism. J Neurol (2012) 0.81
Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke Study. BMC Neurol (2009) 0.77
White matter hyperintensity lesion burden is associated with the infarct volume and 90-day outcome in small subcortical infarcts. Acta Neurol Scand (2016) 0.76
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Lacunar strokes and infarcts: a review. Neurology (1982) 5.39
LACUNES: SMALL, DEEP CEREBRAL INFARCTS. Neurology (1965) 3.73
The arterial lesions underlying lacunes. Acta Neuropathol (1968) 3.06
How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychiatry (2000) 2.72
Basilar artery branch occlusion: a cause of pontine infarction. Neurology (1971) 2.31
Capsular infarcts: the underlying vascular lesions. Arch Neurol (1979) 2.30
Risk factors for lacunar infarction syndromes. Neurology (1995) 1.97
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease. Stroke (2003) 1.76
[Arteries of the human thalamus. II. Arteries and paramedian thalamic territory of the communicating basilar artery]. Rev Neurol (Paris) (1976) 1.71
Does a relationship exist between carotid stenosis and lacunar infarction? Stroke (2003) 1.68
Bilateral thalamic infarction. Clinical, etiological and MRI correlates. Acta Neurol Scand (2001) 1.63
Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke (2000) 1.57
Diffusion-weighted imaging of patients with subacute cerebral ischemia: comparison with conventional and contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2000) 1.49
Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke (1990) 1.45
Multiple acute stroke syndrome: marker of embolic disease? Neurology (2000) 1.40
Diffusion-weighted MRI for the "small stuff": the details of acute cerebral ischaemia. Lancet Neurol (2004) 1.31
Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke (1991) 1.28
Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology (2000) 1.20
Clinical study of 222 patients with pure motor stroke. J Neurol Neurosurg Psychiatry (2001) 1.18
Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke (1999) 1.10
Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke (2002) 1.05
Are multiple acute small subcortical infarctions caused by embolic mechanisms? J Neurol Neurosurg Psychiatry (2004) 1.02
Should computed tomography appearance of lacunar stroke influence patient management? J Neurol Neurosurg Psychiatry (1999) 1.00
Lacunar versus non-lacunar infarcts: pathogenetic and prognostic differences. J Neurol Neurosurg Psychiatry (1992) 0.99
Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke (2002) 0.90
The clinical significance of diffusion-weighted MR imaging in infratentorial strokes. Neurology (2004) 0.89
Lacunar cerebral infarct and nuclear magnetic resonance. A review of sixty cases. Eur Neurol (1990) 0.83
Atrial fibrillation with small subcortical infarcts. J Neurol Neurosurg Psychiatry (2001) 0.79
Editorial comment: The fall and rise of lacunar infarction with carotid stenosis. Stroke (2003) 0.78
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet (2006) 7.88
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol (2008) 2.53
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol (2000) 2.07
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg (1989) 1.89
White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke (1988) 1.85
Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology (1993) 1.85
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology (1999) 1.80
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med (2001) 1.69
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol (2009) 1.53
MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology (1999) 1.50
Diffusion-weighted imaging of patients with subacute cerebral ischemia: comparison with conventional and contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2000) 1.49
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol (1992) 1.44
Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. Stroke (1995) 1.43
Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol (2011) 1.42
Acupuncture using laser needles modulates brain function: first evidence from functional transcranial Doppler sonography and functional magnetic resonance imaging. Lasers Med Sci (2004) 1.37
Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci (2001) 1.37
Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci (1995) 1.36
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol (1994) 1.30
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology (1994) 1.24
Degree of conversion and temperature rise during polymerization of composite resin samples with blue diodes. J Oral Rehabil (2001) 1.20
Diffusion-weighted imaging with navigated interleaved echo-planar imaging and a conventional gradient system. Radiology (1999) 1.20
MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol (1996) 1.20
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med (2000) 1.19
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Assessment of MRI criteria for a diagnosis of MS. Neurology (1993) 1.17
Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet (1996) 1.17
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology (2012) 1.17
Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke (1986) 1.14
Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler (2009) 1.11
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol (2006) 1.10
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke (2000) 1.05
Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy. Stroke (1991) 1.05
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology (2009) 1.04
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology (2007) 1.04
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Composite conversion and temperature rise using a conventional, plasma arc, and an experimental blue LED curing unit. J Oral Rehabil (2002) 1.04
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04
Long-term follow-up after treatment of intracranial aneurysms with the Pipeline embolization device: results from a single center. AJNR Am J Neuroradiol (2011) 1.02
Walking performance and its recovery in chronic stroke in relation to extent of lesion overlap with the descending motor tract. Exp Brain Res (2007) 1.01
Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol (2000) 1.00
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2001) 1.00
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol (2010) 1.00
Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol (1999) 1.00
Influence of light intensity from different curing units upon composite temperature rise. J Oral Rehabil (2005) 1.00
EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol (2006) 0.99
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler (2010) 0.98
Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med (1998) 0.98
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology (2006) 0.97
A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting. Eur J Neurol (2006) 0.97
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol (2006) 0.97
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology (2010) 0.97
Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology (1994) 0.97
Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc (1996) 0.96
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Superficial siderosis of the central nervous system: MRI findings and clinical significance. Neuroradiology (1996) 0.96
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry (2009) 0.95
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis (2006) 0.95
Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol (1991) 0.94
Increased nitric oxide stress is associated with migraine. Cephalalgia (2010) 0.94